Astra Industrial Group announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

July 30, 2026

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	775,872,842	715,112,301	8.496	790,909,047	-1.901
Gross Profit (Loss)	384,226,035	326,588,983	17.648	385,259,335	-0.268
Operational Profit (Loss)	194,128,148	203,614,307	-4.658	192,085,715	1.063
Net Profit (Loss) Attributable to Shareholders of the Issuer	192,062,164	174,924,439	9.797	173,138,809	10.929
Total Comprehensive Income Attributable to Shareholders of the Issuer	226,525,778	174,796,305	29.594	172,515,689	31.307

All figures are in (Actual) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	1,566,781,889	1,548,840,471	1.158
Gross Profit (Loss)	769,485,370	699,186,986	10.054
Operational Profit (Loss)	386,213,863	392,915,422	-1.705
Net Profit (Loss) Attributable to Shareholders of the Issuer	365,200,973	346,795,535	5.307
Total Comprehensive Income Attributable to Shareholders of the Issuer	399,041,467	351,519,431	13.519
Total Shareholders Equity (after Deducting Minority Equity)	3,081,032,149	2,635,325,509	16.912
Profit (Loss) per Share	4.57	4.33

All figures are in (Actual) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	–	–

All figures are in (Actual) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Sales increase in general due to: Increase in Sales in Pharmaceuticals segment. While noting that there is decrease in Sales in Steel industries segment.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit Increases in general due to: 1. Increase in Gross Profit in all segments. 2. Increase in Other income, net in others segment. 3. Decrease in Finance costs in all segments. While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Sales decrease in general due to: Decrease in Sales in Steel industries segment.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit Increases in general due to: 1. Increase in Other income, net in Others segment. 2. Decrease in Expense for impairment of financial assets mainly in Steel industries segment.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is	Sales increases in general due to: Increase in Sales in Pharmaceuticals segment.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is	Net profit Increases in general due to: 1. Increase in Gross Profit in all segments. 2. Decrease in Finance costs in all segments. While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual.
Statement of the type of external auditor’s report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	NA
Reclassification of Comparison Items	NA
Additional Information	Net Shareholders’ Equity at the end of the period was SR 3,080,392,221/- compared to SR 2,656,733,760/- at the end of the similar period last year with an increase of 16%.